Thrombolytic Therapy and Stroke

There's actually some in vitro data that is a precedent for this kind of finding which I for one was not familiar with prior to meeting you. So when we started thinking about using trombolytic therapy and patients on DOX, we went back to literature and they have been rodent models of IV tromboleysis in rats. We were quite astonished to see that the overall result of a reduced or decreased risk of bleeding holds true odds for different for all these type of selection criteria. There was not one which was superior to the others.